Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px
Document › Details

Shire plc. (6/3/16). "Press Release: Shire to Participate at Two Upcoming Investor Conferences". Lexington, MA.

Organisations Organisation Shire plc (LSE: SHP, Nasdaq: SHPGY, TSX: SHQ)
  Today Shire Ltd. (LSE: SHP, NASDAQ: SHPGY)
  Group Shire (Group)
  Organisation 2 Goldman Sachs International
  Group Goldman Sachs (Group)
Products Product Goldman Sachs Annual Global Healthcare Conference 2016 Rancho Palos Verdes, CA
  Product 2 Jefferies 2016 Global Healthcare Conference New York
Index terms Index term Shire–Goldman Sachs: investor conference, 201606 supply service Shire presents at 37th Annual Global Healthcare Conference
  Index term 2 Shire–Leucadia: investor conference, 201606 supply service Shire presents at Jefferies Healthcare Conference in New York
Persons Person Poulton, Jeff (Shire 201606 CFO)
  Person 2 Steinberg, Perry (Shire 201606 Head of Neuroscience + Commercial Excellence)

Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Jeff Poulton, Chief Financial Officer, will present at the Goldman Sachs 37th Annual Global Healthcare Conference on June 8, 2016 at 10:40 a.m. PDT (6:40 p.m. BST) and Perry Sternberg, Head of Neuroscience and Commercial Excellence will present at the Jefferies 2016 Healthcare Conference on June 9, 2016 at 11:30 a.m. EDT (4:30 p.m. BST).

The live audio webcasts of both events will be available on the Presentations and Webcasts section of Shire's Investor website at Subsequently, a replay of both events will be available on this same website.

For further information please contact:

Investor Relations
Sarah Elton-Farr +44 1256 894157
Ian Karp +1 781 482 9018
Robert Coates +44 1256 894874


Shire is the leading global biotechnology company focused on serving people with rare diseases and other highly specialized conditions. We have best-in-class products available in more than 100 countries across core therapeutic areas including Hematology, Immunology, Neuroscience, Lysosomal Storage Disorders, Gastrointestinal / Internal Medicine / Endocrine and Hereditary Angioedema; a growing franchise in Oncology; and an emerging, innovative pipeline in Ophthalmics.

Our employees come to work every day with a shared mission: to develop and deliver breakthrough therapies for the hundreds of millions of people in the world affected by rare diseases and other high-need conditions, and who lack effective therapies to live their lives to the fullest.

Record changed: 2017-07-02


Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

More documents for Shire (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUS] – The Business Web Portal 600x60px

» top